Dr. Pallavi P. Kumar, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
2401 W Belvedere Ave
Baltimore, MD 21215
Who else practices at this address →
Baltimore city includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- East Tennessee State University Quillen College of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 204
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: East Tennessee State University Quillen College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
MD license D0057256
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sinai Hospital of Baltimore Baltimore, MD
- Northwest Hospital Center Randallstown, MD
- Carroll Hospital Center Westminster, MD
Medical groups
- Sinai Hospital of Baltimore, Inc (380 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 204
- Services billed
- 684
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 256 | 73 |
| Established patient office or other outpatient visit, 40-54 minutes | 156 | 54 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 30 | 30 |
| New patient office or other outpatient visit, 60-74 minutes | 28 | 28 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 20 | 20 |
| Telephone or internet assessment with verbal and written report by consulting physician, more than 30 minutes | 14 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prochlorperazine Maleate Other prescribers in Baltimore, MD | 40 |
| Ondansetron Hcl Other prescribers in Baltimore, MD | 30 |
| Lidocaine-Prilocaine (lidocaine/prilocaine) Other prescribers in Baltimore, MD | 24 |
| Dexamethasone Other prescribers in Baltimore, MD | 18 |
| Gabapentin Other prescribers in Baltimore, MD | 18 |
| Eliquis (apixaban) Other prescribers in Baltimore, MD | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $8,549 in research payments for these studies, mostly to the institutions running them.
- Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
AbbVie Inc. · Active, not recruiting · NCT05445778 - Caris Biorepository Research Protocol
Caris Mpi, Inc. · Recruiting · NCT01499394
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.